26.06.2017 • News

Polytek and CMI Set to Merge

(c) XXLPhoto/Shutterstock
(c) XXLPhoto/Shutterstock

US specialty polymer firms Polytek Development Corp. and California Medical Innovations (CMI) are to merge their businesses. The combined company will be led by Polytek CEO Jonathan Kane.

Financial terms of the transaction were not disclosed.

"The merger of the two companies creates a portfolio of products for our industries, unmatched by any competitor in the world, with a coast-to-coast presence that allows us to respond more quickly than ever before," Kane said.

Based in Easton, Pennsylvania, Polytek makes specialty polymers, including polyurethane elastomers and casting resins, silicones, epoxies and latex, used primarily in mold-making and casting applications for the industrial, construction, entertainment, fine arts and technology sectors.

CMI of Pomona, California, formulates and compounds latex, plastisols and thermoplastic elastomers for a variety of industries.

The companies said the merger will enhance their performance and provide a stronger nationwide presence. In addition, the collaboration of their R&D departments and sophisticated manufacturing facilities at both locations will offer more opportunities for customized solutions.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

most read